Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate

Logo Tollys


Doctors Marc Bonnin and Sylvain Thierry will present Tollys’ results at the European Association of Cancer Research’s EACR 2021 Congress, which will take place from June 9 -12


A new dimension in immuno-oncology


60F avenue Rockefeller
69008 Lyon, FRANCE

Contact us